Oxford Vaccine Group, Department of Paediatrics, University of Oxford receives £7.8 million in research funding to fight pandemic and epidemic threats

Published on December 12, 2023

Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pandemic potential. The awards will fund research into vaccines against:

  • Chikungunya and mayaro virus
  • Marburg virus
  • Plague (Yersinia pestis)
  • Q Fever (Coxiella burneti)
  • Sudan Ebolavirus
Continue reading on website
Other news

Unprecedented conservation triumph: Saiga antelope return from the red list

December 12, 2023
Antelope, which roamed the Eurasian Steppe alongside woolly mammoths, has been restored from near extinction by conservation efforts.

Expert Comment: It is remarkable how much we agree. COP28 and the transition from fossil fuels

December 13, 2023
So, COP28 has just called for “transitioning away from fossil fuels in energy systems, in a just, orderly and equitable manner, accelerating action in this critical decade, so as to achieve net zero by 2050 in keeping with the science”. Is this the moment that the world finally decided to hit the brakes, even if ever so gently, on fossil-fuelled global warming? By Professor Myles Allen, professor